Eric M. Eastman
Profile
Eric M.
Eastman held several positions in various companies, including Chief Scientific Officer, SVP & Chairman-SAB at Xceed Molecular Corp., Director-Gene Expression at gMed., Inc., Chief Technology Officer & Senior Vice President at Gene Logic, Inc., President at Morphochem, Inc., Chief Science Officer at DioGenix, Inc., Chief Scientific Officer & Vice President at Lark Sequencing Technologies, Inc., and Chief Scientific & Operations Officer at Genetraks Holdings Ltd.
Eastman received his undergraduate degree from Middlebury College, his graduate degree from the University of Connecticut, and his doctorate from The Trustees of Columbia University in The City of New York.
Former positions of Eric M. Eastman
| Companies | Position | End |
|---|---|---|
Morphochem, Inc.
 Morphochem, Inc. Pharmaceuticals: MajorHealth Technology Morphochem, Inc. manufactures and develops drugs. It uses proprietary whole-cell high throughput screening systems to discover novel compounds of therapeutic value for disorders including cancer & immunological, infectious & metabolic diseases, and for applications in agriculture. The company was founded by Prabhavathi Fernandes in 1997 and is located in Monmouth Junction, NJ | President | 2010-06-30 |
Genetraks Holdings Ltd.
 Genetraks Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Genetraks Holdings Ltd. provides business support services. | Chief Operating Officer | - |
| Lark Sequencing Technologies, Inc. | Chief Tech/Sci/R&D Officer | - |
gMed., Inc.
 gMed., Inc. BiotechnologyHealth Technology gMed is engaged in providing physicians with information solutions to “Care Better” for their patients and practice. The company provides Digital Charting solutions for Gastroenterology and Cardiology designed to eliminate paper, increase revenues, decrease costs and enhance patient care at the medical office, ambulatory surgery center and hosptial. gMED was founded in 1997 and is located in Weston, FL. | Corporate Officer/Principal | - |
Xceed Molecular Corp.
 Xceed Molecular Corp. Medical SpecialtiesHealth Technology Xceed Molecular Corporation is a molecular diagnostic company dedicated to commercializing a platform for automated gene expression analysis and developing proprietary clinical research assays and custom arrays. They develop tools and content aimed at accelerating the current market trend towards 'translational medicine', and bridging the gap from gene signature validation to clinical diagnostics. The Ziplex Automated Workstation is the first integrated and fully automated hybridization system for multiplex gene expression signatures. Their integrated solution - the Ziplex System - features this innovative instrument platform and focused-content TipChip arrays and reagents to perform highly multiplexed molecular assays with superior accuracy, reproducibility, speed and scalability. The Ziplex System is designed to provide the ease-of-use in assay automation and analytics that is required to successfully translate gene expression analysis from research use into routine practice. Xceed complements the Ziplex platform by offering Gene Expression Services and Assay Development Services. | Chief Tech/Sci/R&D Officer | - |
Training of Eric M. Eastman
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| Middlebury College | Undergraduate Degree |
| University of Connecticut | Graduate Degree |
Experiences
Positions held
Linked companies
| Private companies | 7 |
|---|---|
gMed., Inc.
gMed., Inc. BiotechnologyHealth Technology gMed is engaged in providing physicians with information solutions to “Care Better” for their patients and practice. The company provides Digital Charting solutions for Gastroenterology and Cardiology designed to eliminate paper, increase revenues, decrease costs and enhance patient care at the medical office, ambulatory surgery center and hosptial. gMED was founded in 1997 and is located in Weston, FL. | Health Technology |
Gene Logic, Inc.
 Gene Logic, Inc. BiotechnologyHealth Technology Gene Logic, Inc. provides drug discovery and development services to pharmaceutical and biotechnology companies worldwide. The company operates in three segments: Genomics and Toxicogenomics Services, Preclinical Contract Research Services, and Drug Repositioning and Selection Services. Gene Logic was incorporated in 1994 and is headquartered in Gaithersburg, Maryland. | Health Technology |
Xceed Molecular Corp.
Xceed Molecular Corp. Medical SpecialtiesHealth Technology Xceed Molecular Corporation is a molecular diagnostic company dedicated to commercializing a platform for automated gene expression analysis and developing proprietary clinical research assays and custom arrays. They develop tools and content aimed at accelerating the current market trend towards 'translational medicine', and bridging the gap from gene signature validation to clinical diagnostics. The Ziplex Automated Workstation is the first integrated and fully automated hybridization system for multiplex gene expression signatures. Their integrated solution - the Ziplex System - features this innovative instrument platform and focused-content TipChip arrays and reagents to perform highly multiplexed molecular assays with superior accuracy, reproducibility, speed and scalability. The Ziplex System is designed to provide the ease-of-use in assay automation and analytics that is required to successfully translate gene expression analysis from research use into routine practice. Xceed complements the Ziplex platform by offering Gene Expression Services and Assay Development Services. | Health Technology |
Morphochem, Inc.
Morphochem, Inc. Pharmaceuticals: MajorHealth Technology Morphochem, Inc. manufactures and develops drugs. It uses proprietary whole-cell high throughput screening systems to discover novel compounds of therapeutic value for disorders including cancer & immunological, infectious & metabolic diseases, and for applications in agriculture. The company was founded by Prabhavathi Fernandes in 1997 and is located in Monmouth Junction, NJ | Health Technology |
DioGenix, Inc.
 DioGenix, Inc. Medical SpecialtiesHealth Technology DioGenix, Inc. develops and commercializes novel, non-invasive diagnostic, prognostic and treatment response monitoring tests. Its program is designed to provide neurologists with a comprehensive set of clinical tests to diagnose early-stage MS, segment MS patients into clinical sub-types and predict response to treatment, all using non-invasive blood tests. The company was founded by Cam Gallagher, Douglas W. Bigwood and Larry M. Tiffany in September 2008 and is headquartered in Gaithersburg, MD. | Health Technology |
| Lark Sequencing Technologies, Inc. | |
Genetraks Holdings Ltd.
Genetraks Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Genetraks Holdings Ltd. provides business support services. | Commercial Services |
- Stock Market
- Insiders
- Eric M. Eastman
